Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma

Circulatory Shock

Volumn 43, Issue 4, 1994, Pages 191-197

  Lejeune, F J ^a   Lienard, D ^a   Eggermont, A ^a   Koops, H S ^a   Kroon, B ^a   Gerain, J ^a   Rosenkaimer, F ^a   Schmitz, P ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

biochemotherapy; interferon ; isolated perfusion of the limbs; melphalan; rTNF

Indexed keywords

MELPHALAN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; HUMAN; HYPERTHERMIC THERAPY; LIVER TOXICITY; LUNG TOXICITY; MELANOMA; NEPHROTOXICITY; PRIORITY JOURNAL; SEPTIC SHOCK; SHOCK;

ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; MALE; MELANOMA; MELANOMA, EXPERIMENTAL; PERFUSION, REGIONAL; SHOCK, SEPTIC; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0028641633     PISSN: 00926213     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)